According to a recent release, Beyond Limits, an artificial intelligence (AI) and cognitive computing company, has appointed Dr. Manikanda Arunachalam, Cardiologist and Venture Capital specialist, as its new Senior Vice President for Corporate Development and Investments. Arunachalam will lead Beyond Limits as it expands and adapts its technology for the healthcare and health tech space, with the goal of bringing cognitive AI solutions to the sector via its Life Sciences platform.
“Beyond Limits’ Life Sciences platform provides transformative value proposition to diverse stakeholders in the healthcare industry that could improve clinical outcomes, optimize costs and build sustainable business models,” said Arunachalam. “Beyond Limits Life Sciences will be an ideal partner for health systems, care plans, CRO's, genomics companies and many other providers in digital health and healthcare Internet of Things.”
Arunachalam is a multi-disciplinary professional with expertise in venture capital and private equity, specializing in medical devices, genomics, digital health and Healthcare IOT. He is a partner in DS Investments, where he focuses on healthcare technology investments. In addition, he serves on the board of HD Medical Group and is a Strategic Advisor to Guardant Health. Prior to joining Beyond Limits, he served on the Board of Directors at the KEF Company, overseeing its multi-million dollar healthcare investment portfolio. In addition, he has served in key strategic and management roles at Capricorn Healthcare and Special Opportunities Fund, Motherhood India, and Johnson & Johnson Medical Devices.
“Beyond Limits’ fast, agile, and cognitive AI technology is an ideal partner for the healthcare industry, where it can be adapted to numerous roles including patient care, data security, and automation of medical devices,” said AJ Abdallat, CEO, Beyond Limits. “With his combined strengths in business development and health technology, as well as strong clinical experience, Dr. Mani is the perfect person to lead our team as we expand into the healthcare space.”